Obesity is recognized as a significant risk factor for Alzheimer's disease (AD). Studies have
supported that obesity accelerates AD-related pathophysiology and memory impairment in …

Background Hallucinations are transmodal and transdiagnostic phenomena, occurring across
sensory modalities and presenting in psychiatric, neurodegenerative, neurological, and …

Introduction The heterogeneity of symptoms and complex etiology of depression pose a
significant challenge to the personalization of treatment. Meanwhile, the current application of …

All perception is a construction of the brain from sensory input. Our first perceptions begin
during gestation, making fetal brain development fundamental to how we experience a diverse …

Background Psychological therapies are effective for treating major depressive disorder, but
current clinical guidelines do not provide guidance on the personalization of treatment …

Animal models of Alzheimer’s disease (AD) can be used to determine the progressive
neurodegeneration characteristics of AD in vivo using magnetic resonance imaging (MRI). Given …

Background: Deep learning has utility in predicting differential antidepressant treatment
response among patients with major depressive disorder, yet there remains a paucity of …

Aifred Health, one of the top two teams in the first round of the IBM Watson AI XPRIZE
competition, is using deep learning to solve the problem of treatment selection and prognosis …

Aifred is a clinical decision support system (CDSS) that uses artificial intelligence to assist
physicians in selecting treatments for major depressive disorder (MDD) by providing …

Background Approximately two-thirds of patients with major depressive disorder do not
achieve remission during their first treatment. There has been increasing interest in the use of …